Ligand validation:6EHC

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6EHC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EHC_C8E_A_402	24%	91%	0.104	0.85	0.29	0.28	-	-	0	0	33%	1
6EHC_C8E_A_403	21%	86%	0.1	0.811	0.33	0.38	-	-	0	0	43%	1
6EHC_C8E_A_404	19%	86%	0.13	0.846	0.4	0.33	-	-	0	0	33%	1
6EHC_C8E_B_404	16%	81%	0.277	0.929	0.31	0.51	-	-	0	0	57%	0.33
6EHC_C8E_B_402	15%	87%	0.166	0.817	0.4	0.29	-	-	2	0	48%	1
6EHC_C8E_A_405	13%	71%	0.165	0.755	0.5	0.62	-	-	0	0	71%	1
6EHC_C8E_B_401	8%	63%	0.289	0.826	0.64	0.77	-	-	0	0	67%	1
6EHC_C8E_B_403	8%	89%	0.201	0.776	0.39	0.24	-	-	0	0	43%	1
6EHC_C8E_A_406	6%	91%	0.275	0.825	0.43	0.15	-	-	0	0	38%	1
6EHC_C8E_A_401	4%	93%	0.137	0.644	0.38	0.09	-	-	0	0	29%	1
6EHB_C8E_A_403	46%	67%	0.098	0.919	0.56	0.72	-	-	1	0	52%	1
5ONU_C8E_A_401	33%	84%	0.168	0.846	0.37	0.4	-	-	1	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.